Immunotherapy — CAR-T therapy revolutionize the cancer treatment
There is a rapidly emerging immunotherapy approach called cancer immunotherapy. This approach consists of collecting and using someone‘s own immune cells to treat their cancer. To learn more…
CAR T-cell therapy is a form of immunotherapy that uses T–cells from a patient’s own immune system to help them fight cancer. Typically, a sample of a patient’s T–cells are collected from their blood, then modified to produce special structures called chimeric antigen receptors (CARs) on their surface. When these CAR T–cells are re–infused into the patient, the new receptors enable them to latch onto and kill specific antigens on the patient’s tumor cells.
CAR T-Cell therapy’s progress so far
CAR T-cell immunotherapy uses one’s own immune cells to fight cancer
Two CAR T-cell therapies received FDA approval in 2017 for treating B cell leukemia and lymphoma
Both CAR T-cell therapies have reported over 80% response rate in the intended-to-treat cancer patient group for the patients who fail chemotherapy and radiation
Thousands of cancer patients have entered remission following CAR T-cell treatment
Billions of dollars are currently funding over 800 CAR T-cell clinical trials worldwide targeting every different cancer types.
With increased focus and technology, many more breakthroughs are expected in fighting against cancer with our own cells